|
|
|
|
|
Received: 10 October 2020
|
|
|
|
|
|
[1] 黎云,高日扬,林小亮,等.厄贝沙坦联合美托洛尔治疗慢性心力衰竭合并房性或室性心律失常患者的疗效[J].心血管康复医学杂志,2019,28(4):466-469.
[2] 廖晓星,李恒杰.心力衰竭合并心律失常药物治疗[J].中国实用内科杂志志,2014,34(11):1057-1059.
[3] 王凤,杜文婷,章怡祎,等.辨病症论治心律失常概况与展望[J].中国实验方剂学杂志,2015,21(13):217-219. |
| [1] |
. [J]. journal1, 2021, 41(6): 43-44. |
| [2] |
Cai Qinhong, Wu Haolong. Effect of Trimetazidine Combined With Perindopril on LVEDd and LVESD in Patients With Heart Failure[J]. journal1, 2021, 41(4): 8-9. |
| [3] |
Li Jingjing. Effect of Yiqi Tongmai Decoction on Cardiac Function and Inflammatory Response in Patients With Coronary Heart Disease and Heart Failure[J]. journal1, 2021, 41(4): 126-127. |
| [4] |
Fu Wenhui, Ren Fengjiao, Zhang Zhao. The Effect of Levosimendancombined With Mechanical Ventilation on Severe Heart Failure in ICU and Its Influence on Heart Function[J]. journal1, 2021, 41(2): 15-17. |
| [5] |
. [J]. journal1, 2021, 41(2): 53-53. |
| [6] |
Dong Chunfang, Zheng Shuaijun, Xu Haojie. The Effect of Irbesartan and Benazepril on Coronary Artery Disease and Hypertension in Patients With Vascular Endothelial Function[J]. journal1, 2021, 41(1): 39-41. |
|
|
|
|
2021, Vol. 41 
